Abstract | BACKGROUND: AIMS: SOURCES: Computer-based Medline searches with MeSH terms pertaining to each agent or therapeutic family. CONTENT: IMPLICATIONS: With the exception of VEGF-targeted agents, the overall risk of infection associated with the reviewed therapies seems to be low.
|
Authors | J Aguilar-Company, M Fernández-Ruiz, R García-Campelo, A C Garrido-Castro, I Ruiz-Camps |
Journal | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
(Clin Microbiol Infect)
Vol. 24 Suppl 2
Pg. S41-S52
(Jun 2018)
ISSN: 1469-0691 [Electronic] England |
PMID | 29426804
(Publication Type: Consensus Development Conference, Journal Article, Review)
|
Copyright | Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- Antineoplastic Agents, Immunological
- Enzyme Inhibitors
- Receptors, Cell Surface
- Vascular Endothelial Growth Factor A
|
Topics |
- Antineoplastic Agents, Immunological
(administration & dosage, adverse effects)
- Biological Therapy
(adverse effects, methods)
- Clinical Trials as Topic
- Communicable Disease Control
- Communicable Diseases
(therapy)
- Consensus
- Enzyme Inhibitors
(adverse effects, therapeutic use)
- Humans
- Immunocompromised Host
- Molecular Targeted Therapy
(adverse effects, methods)
- Receptors, Cell Surface
(antagonists & inhibitors)
- Signal Transduction
(drug effects)
- Vascular Endothelial Growth Factor A
(drug effects)
|